Tema Heart & Health ETF (NASDAQ:HRTS) Sees Significant Increase in Short Interest

Tema Heart & Health ETF (NASDAQ:HRTS) saw a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 5,095 shares, an increase of 797.0% from the July 15th total of 568 shares. Currently, 0.3% of the company’s shares are short sold. Based on an average daily volume of 9,385 shares, the short-interest ratio is presently 0.5 days.

Tema Heart & Health ETF Price Performance

NASDAQ HRTS traded down $0.07 on Tuesday, reaching $37.72. The company had a trading volume of 1,881 shares, compared to its average volume of 6,243. The firm has a market cap of $56.20 million, a price-to-earnings ratio of 22.06 and a beta of 0.63. Tema Heart & Health ETF has a fifty-two week low of $27.79 and a fifty-two week high of $37.79. The business has a 50 day moving average of $35.87 and a two-hundred day moving average of $34.94.

Institutional Investors Weigh In On Tema Heart & Health ETF

Several institutional investors and hedge funds have recently made changes to their positions in HRTS. Royal Bank of Canada raised its position in shares of Tema Heart & Health ETF by 8.8% during the first quarter. Royal Bank of Canada now owns 21,083 shares of the company’s stock worth $710,000 after acquiring an additional 1,703 shares during the last quarter. Kestra Advisory Services LLC bought a new stake in Tema Heart & Health ETF in the fourth quarter valued at approximately $27,000. Stifel Financial Corp increased its position in Tema Heart & Health ETF by 19.8% during the 4th quarter. Stifel Financial Corp now owns 33,647 shares of the company’s stock valued at $1,187,000 after purchasing an additional 5,571 shares during the period. Citadel Advisors LLC acquired a new stake in Tema Heart & Health ETF during the 3rd quarter valued at approximately $243,000. Finally, Jane Street Group LLC raised its holdings in Tema Heart & Health ETF by 9.4% during the 2nd quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock worth $1,062,000 after purchasing an additional 3,202 shares during the last quarter.

Tema Heart & Health ETF Company Profile

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.